400 reports of this reaction
2.1% of all CLOBETASOL PROPIONATE OINTMENT USP, 0.05% reports
#9 most reported adverse reaction
NAUSEA is the #9 most commonly reported adverse reaction for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, manufactured by Encube Ethicals, Inc.. There are 400 FDA adverse event reports linking CLOBETASOL PROPIONATE OINTMENT USP, 0.05% to NAUSEA. This represents approximately 2.1% of all 18,702 adverse event reports for this drug.
Patients taking CLOBETASOL PROPIONATE OINTMENT USP, 0.05% who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 400 FDA reports for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.1% of all adverse event reports for CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, making it a notable side effect.
If you experience nausea while taking CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.